Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient

Physics in Medicine and Biology

Volumn 58, Issue 4, 2013, Pages 807-823

  Zhang, Rui ^a,b,e   Howell, Rebecca M ^a,b   Giebeler, Annelise ^a,b   Taddei, Phillip J ^a,b,c   Mahajan, Anita ^b   Newhauser, Wayne D ^a,b,d,e  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e MARY BIRD PERKINS CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTRIBUTABLE RISKS; BASELINE PREDICTIONS; BIOLOGICAL EFFECTS; CRANIOSPINAL IRRADIATION; MEDULLOBLASTOMA; MONTE CARLO SIMULATION; PEDIATRIC PATIENTS; PROTON THERAPY; RADIATION WEIGHTING FACTORS; RELATIVE RISKS; SIDE EFFECT; STRAY RADIATION; TREATMENT PLANNING SYSTEMS; TREATMENT PLANS;

BRAIN; DISEASES; MONTE CARLO METHODS; PEDIATRICS; PHOTONS; PROTON BEAMS; PROTONS; RADIOTHERAPY; RISK ASSESSMENT; RISK PERCEPTION; STRAY LIGHT; UNCERTAINTY ANALYSIS;

NEUTRON IRRADIATION;

ALGORITHM; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOSPINAL IRRADIATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDULLOBLASTOMA; METHODOLOGY; MONTE CARLO METHOD; PATHOLOGY; PRESCHOOL CHILD; PROTON THERAPY; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; RISK; SECOND CANCER; TISSUE DISTRIBUTION;

ALGORITHMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; CRANIOSPINAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MEDULLOBLASTOMA; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROTON THERAPY; RADIOTHERAPY, INTENSITY-MODULATED; RISK; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

MLCS; MLOWN;

EID: 84873635973     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/58/4/807     Document Type: Article

References (58)

1. Arias E 2010 United States Life Tables, 2006 National Vital Statistics Reports vol 58 pp 1-40
2. Arjomandy B, Sahoo N, Zhu X R, Zullo J R, Wu R Y, Zhu M, Ding X, Martin C, Ciangaru G and Gillin M T 2009 An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston Med. Phys. 36 2269-82
3. Armstrong G T, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S, Neglia J P, Stovall M, Srivastava D and Robison L L 2011 Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study J. Clin. Oncol. 29 3056-64
4. Bhatti P et al 2010 Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study Radiat. Res. 174 741-52
5. Brenner D J, Curtis R E, Hall E J and Ron E 2000 Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery Cancer 88 398-406
6. Brodin N P, Rosenschold P M, Aznar M C, Kiil-Berthelsen A, Vogelius I R, Nilsson P, Lannering B and Bjork-Eriksson T 2011 Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma Acta Oncol. 50 806-16
7. Choux M, Lena G and Hassoun J 1983 Prognosis and long-term follow-up in patients with medulloblastoma Clin. Neurosurg. 30 246-77
8. Cochran D M, Yock T I, Adams J A and Tarbell N J 2008 Radiation dose to the lens during craniospinal irradiation - an improvement in proton radiotherapy technique Int. J. Radiat. Oncol. Biol. Phys. 70 1336-42
9. del Charco J O, Bolek T W, McCollough W M, Maria B L, Kedar A, Braylan R C, Mickle J P, Buatti J M, Mendenhall N P and Marcus R B Jr 1998 Medulloblastoma: time-dose relationship based on a 30-year review Int. J. Radiat. Oncol. Biol. Phys. 42 147-54
10. Fontenot J D, Bloch C, Followill D, Titt U and Newhauser W D 2010 Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy Phys. Med. Biol. 55 6987-98
11. Fontenot J D, Lee A K and Newhauser W D 2009 Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 74 616-22
12. Fossati P, Ricardi U and Orecchia R 2009 Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy Cancer Treat. Rev. 35 79-96
13. Freeman C R, Taylor R E, Kortmann R D and Carrie C 2002 Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts Med. Pediatr. Oncol. 39 99-108
14. Giebeler A, Howell R, Amos R, Mahajan A and Newhauser W 2013 Standardized treatment planning methodology for passively scattered proton craniospinal irradiation and consistency between individually optimized plans Radiat. Oncol. at press
15. Gottardo N G and Gajjar A 2006 Current therapy for medulloblastoma Curr. Treat. Options Neurol. 8 319-34
16. Hall E J and Wuu C S 2003 Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int. J. Radiat. Oncol. Biol. Phys. 56 83-8
17. Hendricks J S, McKinney G W, Durkee J W, Finch J P, Fensin M L, James M R, Johns R C, Pelowitz D B, Waters L S and Gallmeier F X 2006 MCNPX, Version 26c, Los Alamos National Laboratory
18. Hoppe-Hirsch E, Renier D, Lellouch-Tubiana A, Sainte-Rose C, Pierre-Kahn A and Hirsch J F 1990 Medulloblastoma in childhood: progressive intellectual deterioration Child's Nerv. Syst. 6 60-5
19. Howell R, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel C, D'Amelio A M Jr, Homann K L and Newhauser W D 2012 Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma Radiat. Oncol. 7 116-27
20. Howell R M, Scarboro S B, Kry S F and Yaldo D Z 2010a Accuracy of out-of-field dose calculations by a commercial treatment planning system Phys. Med. Biol. 55 6999-7008
21. Howell R M, Scarboro S B, Taddei P J, Krishnan S, Kry S F and Newhauser W D 2010b Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy Phys. Med. Biol. 55 7009-23
22. ICRP 2003 Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR ) Publication 92 Ann. ICRP 33 1-117
23. Inskip P D and Curtis R E 2007 New malignancies following childhood cancer in the United States, 1973-2002 Int. J. Cancer 121 2233-40
24. Jiang H, Wang B, Xu X G, Suit H D and Paganetti H 2005 Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment Phys. Med. Biol. 50 4337-53
25. Kellerer A M, Ruhm W and Walsh L 2006 Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors Health Phys. 90 554-64
26. Kiltie A E, Lashford L S and Gattamaneni H R 1997 Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old Med. Pediatr. Oncol. 28 348-54
27. Lee C T, Bilton S D, Famiglietti R M, Riley B A, Mahajan A, Chang E L, Maor M H, Woo S Y, Cox J D and Smith A R 2005 Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int. J. Radiat. Oncol. Biol. Phys. 63 362-72
28. Lin R, Hug E B, Schaefer R A, Miller D W, Slater J M and Slater J D 2000 Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures Int. J. Radiat. Oncol. Biol. Phys. 48 1219-26
29. Meadows A T, Friedman D L, Neglia J P, Mertens A C, Donaldson S S, Stovall M, Hammond S, Yasui Y and Inskip P D 2009 Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort J. Clin. Oncol. 27 2356-62
30. Miralbell R, Lomax A, Bortfeld T, Rouzaud M and Carrie C 1997a Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume Int. J. Radiat. Oncol. Biol. Phys. 38 477-84
31. Miralbell R, Lomax A, Cella L and Schneider U 2002 Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors Int. J. Radiat. Oncol. Biol. Phys. 54 824-9
32. Miralbell R, Lomax A and Russo M 1997b Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation Int. J. Radiat. Oncol. Biol. Phys. 38 805-11
33. Mu X, Bjoerk-Eriksson T, Nill S, Oelfke U, Johansson K-A, Gagliardi G, Johansson L, Karlsson M and Zackrisson D B 2005 Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study Acta Oncol. 44 554-62
34. Mulhern R K, Kepner J L, Thomas P R, Armstrong F D, Friedman H S and Kun L E 1998 Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a pediatric oncology group study J. Clin. Oncol. 16 1723-8
35. NCRP 2011 Second primary cancers and cardiovascular disease after radiation therapy Report 170 (Bethesda, MD: NCRP)
36. Newhauser W 2010 Complexity of advanced radiation therapy necessitates multidisciplinary inquiry into dose reconstruction and risk assessment Phys. Med. Biol. 55 (23) E01
37. Newhauser W, Fontenot J, Zheng Y, Polf J, Titt U, Koch N, Zhang X and Mohan R 2007 Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm Phys. Med. Biol. 52 4569-84
38. Newhauser W D et al 2009 The risk of developing a second cancer after receiving craniospinal proton irradiation Phys. Med. Biol. 54 2277-91
39. Newhauser W D, Zheng Y, Taddei P J, Mirkovic D, Fontenot J, Giebeler A, Zhang R, Titt U and Mohan R 2008 Monte Carlo proton radiation therapy planning calculations Trans. Am. Nucl. Soc. 99 63-4
40. NRC 2006 Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII - Phase 2 (Washington, DC: Nation Research Council of the National Academies)
41. Packer R J et al 2006 Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma J. Clin. Oncol. 24 4202-8
42. Packer R J and Vezina G 2008 Management of and prognosis with medulloblastoma: therapy at a crossroads Arch. Neurol. 65 1419-24
43. Rechner L A, Howell R M, Zhang R, Etzel C, Lee A K and Newhauser W D 2012 Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer Phys. Med. Biol. 57 7117-32
44. Ronckers C M et al 2006 Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers Radiat. Res. 166 618-28
45. Schneider U and Kaser-Hotz B 2005 A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy Z. Med. Phys. 15 31-7
46. Schneider U, Lomax A and Timmermann B 2008 Second cancers in children treated with modern radiotherapy techniques Radiother. Oncol. 89 135-40
47. Schneider U and Walsh L 2008 Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy Radiat. Environ. Biophys. 47 253-63
48. Schneider U, Zwahlen D, Ross D and Kaser-Hotz B 2005 Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose Int. J. Radiat. Oncol. Biol. Phys. 61 1510-5
49. Sigurdson A J et al 2005 Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study Lancet 365 2014-23
50. St Clair W H, Adams J A, Bues M, Fullerton B C, La Shell S, Kooy H M, Loeffler J S and Tarbell N J 2004 Advantage of protons compared to conventional x-ray or IMRT in the treatment of a pediatric patient with medulloblastoma Int. J. Radiat. Oncol. Biol. Phys. 58 727-34
51. Stovall M, Blackwell C R, Cundiff J, Novack D H, Palta J R, Wagner L K, Webster E W and Shalek R J 1995 Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36 Med. Phys. 22 63-82
52. Taddei P J, Mahajan A, Mirkovic D, Zhang R, Giebeler A, Kornguth D, Harvey M, Woo S and Newhauser W D 2010 Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation Phys. Med. Biol. 55 7067-80
53. Taddei P J, Mirkovic D, Fontenot J D, Giebeler A, Zheng Y, Kornguth D, Mohan R and Newhauser W D 2009 Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams Phys. Med. Biol. 54 2259-75
54. Tarbell N J, Smith A R, Adams J and Loeffler J S 2000 The challenge of conformal radiotherapy in the curative treatment of medulloblastoma Int. J. Radiat. Oncol. Biol. Phys. 46 265-6
55. Yepes P P, Mirkovic D and Taddei P J 2010 A GPU implementation of a track-repeating algorithm for proton radiotherapy dose calculations Phys. Med. Biol. 55 7107-20
56. Yom S S, Frija E K, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J and Woo S 2007 Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation Int. J. Radiat. Oncol. Biol. Phys. 69 1193-8
57. Zacharatou Jarlskog C and Paganetti H 2008 Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age Int. J. Radiat. Oncol. Biol. Phys. 72 228-35
58. Zhang G, Liu Q, Zeng S and Luo Q 2008 Organ dose calculations by Monte Carlo modeling of the updated VCH adult male phantom against idealized external proton exposure Phys. Med. Biol. 53 3697-722